|
Meno:
|
doc. MUDr. Richard Imrich, DrSc. | |
|
Email:
|
richard.imrich@ucm.sk | |
|
Homepage:
|
http:// | |
|
Fakulta/Univerzita:
|
FZV UCM
-
Fakulta zdravotníckych vied
|
|
|
Pracovisko:
|
KKD
-
Katedra klinických disciplín
|
| III.a - Zamestnanie-pracovné zaradenie | III.b - Inštitúcia | III.c - Časové vymedzenie |
|---|---|---|
| prednosta | Lekárska fakulta UK v Bratislave | 2025-trvá |
| vedúci vedecký pracovník | Biomedicínske centrum SAV | 2001-trvá |
| docent | Fakulta zdravotníckych vied UCM | 2021-trvá |
| V.1.a - Názov profilového predmetu | V.1.b - Študijný program | V.1.c - Stupeň | V.1.d - Študijný odbor |
|---|---|---|---|
| Anatómia a fyziológia I a II | fyzioterapia, rádiologická technika | I. | zdravotnícke vedy |
Radikova Z, Mosna L, Eckerstorfer C, Bajer B, Havranova A, Imrich R, Vlcek M, Penesova A. Plasma irisin and the brain-derived neurotrophic factor levels in sedentary subjects: effect of 8-weeks lifestyle intervention. Endocr Regul. 2024 Jun 11;58(1):115-128.
Ranganath LR, Khedr M, Milan AM, Davison AS, Hughes AT, Norman BP, Bygott H, Luangrath E, Judd S, Soulsby C, Olsson B, Imrich R. Anthropometric, Body Composition, and Nutritional Indicators with and without Nutritional Intervention during Nitisinone Therapy in Alkaptonuria. Nutrients. 2024 Aug 15;16(16):2722.
Rajnák C, Imrich R, Štofko J, Matonok A, Boča R. Molecular Properties of Monoaminergic Catecholamines in Water. ACS Omega. 2024 Aug 18;9(34):36086-36098.
Boča R, Imrich R, Štofko J, Vranovičová B, Rajnák C. Molecular Properties of Branched Aliphatic α-Amino Acids in Water. J Phys Chem A. 2024 Sep 26;128(38):8088-8095.
Taylor S, Dobbin N, Imrich R, Arnoux JB, Ranganath LR.The effects of age and sex on active and passive hip range of motion in individuals with alkaptonuria. Disabil Rehabil. 2025 Jan 8:1-6.
Radikova Z, Mosna L, Eckerstorfer C, Bajer B, Havranova A, Imrich R, Vlcek M, Penesova A. Plasma irisin and the brain-derived neurotrophic factor levels in sedentary subjects: effect of 8-weeks lifestyle intervention. Endocr Regul. 2024 Jun 11;58(1):115-128.
Ranganath LR, Khedr M, Milan AM, Davison AS, Hughes AT, Norman BP, Bygott H, Luangrath E, Judd S, Soulsby C, Olsson B, Imrich R. Anthropometric, Body Composition, and Nutritional Indicators with and without Nutritional Intervention during Nitisinone Therapy in Alkaptonuria. Nutrients. 2024 Aug 15;16(16):2722.
Rajnák C, Imrich R, Štofko J, Matonok A, Boča R. Molecular Properties of Monoaminergic Catecholamines in Water. ACS Omega. 2024 Aug 18;9(34):36086-36098.
Boča R, Imrich R, Štofko J, Vranovičová B, Rajnák C. Molecular Properties of Branched Aliphatic α-Amino Acids in Water. J Phys Chem A. 2024 Sep 26;128(38):8088-8095.
Taylor S, Dobbin N, Imrich R, Arnoux JB, Ranganath LR.The effects of age and sex on active and passive hip range of motion in individuals with alkaptonuria. Disabil Rehabil. 2025 Jan 8:1-6.
[o1] 2014 ~ Elsen, M. - Raschke, S. - Eckel, J.: Browning of white fat : does irisin play a role in humans?. In: Journal of endocrinology, roč. 222, č. 1, 2014, s. R25-R38 -- SCI ; SCOPUS
[o1] 2014 ~ Ruchala, M. - Zybek, A. - Szczepanek-Parulska, E.: Serum irisin levels and thyroid function - Newly discovered association. In: Peptides, roč. 60, 2014, s. 51-55 -- SCI ; SCOPUS
[o1] 2014 ~ Daskalopoulou, S.S. - Cooke, A.B. - Gomez, Y.-H. - Mutter, A.F. - Filippaios, A. - Mesfum, E.T. - Mantzoros, C.S.: Plasma irisin levels progressively increase in response to increasing exercise workloads in young, healthy, activesubjects. In: European journal of endocrinology, roč. 171, č. 3, 2014, s. 343-352 -- SCI ; SCOPUS
[o1] 2014 ~ Anastasilakis, A.D. - Polyzos, S.A. - Saridakis, Z.G. - Kynigopoulos, G. - Skouvaklidou, E.C. - Molyvas, D. - Vasiloglou, M.F. - Apostolou, A. - Karagiozoglou-Lampoudi, T. - Siopi, A. - Mougios, V. - Chatzistavridis, P. -Panagiotou, G. - Filippaios, A. - Delaroudis, S. - Mantzoros, C.S.: Circulating irisin in healthy, young individuals: Day-night rhythm, effects of food intake and exercise, and associations with gender, physical activity, diet, and body composition. In: Journal of clinical endocrinology and metabolis, roč. 99, č. 9, 2014, s. 3247-3255 -- SCI ; SCOPUS
ERA4Health, Fostering a European Research Area for Health Research (HORIZON-HLTH-2022-DISEASE-03), INSTITUTO DE SALUD CARLOS III (ISCIII), Spain, 2022-2029
Role: Co-investigator
FP7-HEALTH-2013-INNOVATION-1 Clinical Development of Nitisinone for Alkaptonuria (DevelopAKUre) 11/2012-2015, EudraCT 2012-005340-24, EudraCT 2013-001633-41
Principal Investigator: Dr L Ranganath (Royal Liverpool University Hospital)
Role: Center Coordinator
SK095 EEA/Norway Grants 2009-2011
Development of the Centre for Molecular Medicine of the Slovak Academy of Sciences as a unique modern clinical research unit in Slovakia
Role: Principal Scientific Coordinator
ATMOS N00024 2009-2012
Rheumatoid arthritis susceptibility genes in Austrian and Slovak population (RASGENAS)
Role: Principal Scientific Coordinator
03-N-0004 Clinical Laboratory Evaluation of Primary Chronic Autonomic Failure
Principal Investigator: David.S. Goldstein, MD, PhD.
Role: Co-Investigator
ClinicalTrials.gov Identifier: NCT00059033